Brigham and Wom­en's pres­i­dent Eliz­a­beth Nabel fol­lows Mon­cef Slaoui off Mod­er­na's board

Amid re­cent scruti­ny on how Mod­er­na’s top ex­ec­u­tives have been cash­ing out their in­creas­ing­ly valu­able shares, the biotech is part­ing ways with a board mem­ber who’s al­so head­ing a hos­pi­tal where its Covid-19 vac­cine is be­ing test­ed.

Eliz­a­beth Nabel — the pres­i­dent of Brigham and Women’s Hos­pi­tal — has fol­lowed in Mon­cef Slaoui’s foot­steps in re­sign­ing from Mod­er­na’s board of di­rec­tors. She took the role in 2015, two years be­fore the Op­er­a­tion Warp Speed leader did; and as with Slaoui and MIT pro­fes­sor Robert Langer, her term was due to ex­pire in 2021.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER